Novel patient derived colorectal cancer organoid platform for automated high throughput drug discovery applications

被引：0
|
作者：
Lim, A. [1 ]
Tong, Z. [1 ]
Fraser, E. [2 ]
Durban, V. [2 ]
Macha, P. [1 ]
Buddhikot, O. [1 ]
Baranowski, T. [1 ]
Baade, J. [1 ]
Katiyar, A. [1 ]
Amijee, H. [2 ]
Sirenko, O. [1 ]
机构：
[1] Mol Devices, San Jose, CA USA
[2] Cellesce Biotechnol, Cardiff, Wales
来源：
MOLECULAR BIOLOGY OF THE CELL | 2023年 / 34卷 / 02期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
B236/P1229
引用
收藏
页码：139 / 140
页数：2
相关论文
共 50 条
  • [31] Patient-derived MTAP-deleted bladder cancer organoid model: A unique platform for drug development
    Schwermann, Maximilian
    Carneiro, Benedito
    Lu, Shaolei
    De Souza, Andre
    Hadfield, Matthew
    Mega, Anthony
    Lagos, Galina
    Khaleel, Sari
    Golijanin, Dragan
    Holder, Sheldon
    Srinivasan, Praveen
    MacDonald, William
    George, Andrew
    Zhou, Lanlan
    Zhang, Leiqing
    El-Deiry, Wafik
    CANCER RESEARCH, 2024, 84 (06)
  • [32] Novel organoid platform for drug screening of patients with breast cancer.
    Shih, Shian-Jiun
    Zhang, Ruobo
    Han, Yi Chun
    Pegram, Mark D.
    Chang, Ying C.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [33] 3D bioprinting platform development for high-throughput cancer organoid models construction and drug evaluation
    Dai, Rui
    Chen, Wei
    Chen, You
    Jin, Jinlong
    Zhang, Shiwei
    Zhang, Changhua
    Liu, Jie
    BIOFABRICATION, 2024, 16 (03)
  • [34] ESTABLISHMENT OF A RELIABLE GLIOBLASTOMA TUMOR-ORGANOID PLATFORM ENABLES AUTOMATED HIGH-THROUGHPUT DRUG SCREENING ADVANCING PERSONALIZED MEDICINE
    Herold-Mende, Christel
    Paul, Adrian
    Cao, Junguo
    Warta, Rolf
    Andreas, Unterberg
    Abdollahi, Amir
    Jungwirth, Gerhard
    NEURO-ONCOLOGY, 2022, 24 : 291 - 291
  • [35] Autologous patient-derived organoid-immune cell co-culture platform for therapeutic discovery in high-grade endometrial cancer
    Chung, Charlie
    Nizam, Aaron
    Yueh, Brian
    Subhash, Santhilal
    Eskiocak, Onur
    Frimer, Marina
    Goldberg, Gary L.
    Beyaz, Semir
    CANCER RESEARCH, 2023, 83 (07)
  • [36] An In Vivo Platform for Rapid High-Throughput Antitubercular Drug Discovery
    Takaki, Kevin
    Cosma, Christine L.
    Troll, Mark A.
    Ramakrishnan, Lalita
    CELL REPORTS, 2012, 2 (01): : 175 - 184
  • [37] Autologous patient-derived organoid-immune cell co-culture platform for therapeutics discovery in high-grade endometrial cancer
    Chung, Charlie
    Nizam, Aaron
    Yueh, Brian
    Subhash, Santhilal
    Frimer, Marina
    Goldberg, Gary L.
    Beyaz, Semir
    CLINICAL CANCER RESEARCH, 2024, 30 (05)
  • [38] Patient-derived Organoid Model for Predicting the Chemoresponse in Patients With Colorectal Cancer
    Yi, Kiyoun
    Park, Sung Hee
    Kim, Dong Uk
    Jeon, Da Ye
    Lee, Hye Ji
    Song, Geun Am
    Jo, Hong Jae
    Baek, Dong Hoon
    Han, Jeong Hee
    Lee, Byoung Chul
    IN VIVO, 2023, 37 (04): : 1751 - 1759
  • [39] Applications of high throughput microsomal stability assay in drug discovery
    Di, Li
    Kerns, Edward H.
    Ma, Xuewen Joann
    Huang, Youping
    Carter, Guy T.
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2008, 11 (06) : 469 - 476
  • [40] Applications of high throughput thermodynamic methods in proteomics & drug discovery
    Salemme, FR
    BIOPHYSICAL JOURNAL, 2003, 84 (02) : 284A - 284A
12345